Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials